share_log

微芯生物:西达本胺治疗结直肠癌临床试验获批

JRJ Finance ·  Jul 23 05:41

微芯生物公告,公司近日收到国家药监局签发的西达本胺联合信迪利单抗和贝伐珠单抗治疗晚期结直肠癌的临床试验批准通知书。该试验为随机、开放性、对照、多中心的Ⅲ期临床试验。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment